By Dr. Alexandra Konowal –
Xeomin (incobotulinumtoxinA) is the latest contender in a growing list of botulinum toxin type A injectables. The Food and Drug Administration (FDA) approved Xeomin in July 2011 for the treatment of severe frown lines or “11’s” between the eyes. This Botox alternative was already approved for use in adults with cervical dystonia and blepharospasm. Cervical dystonia is characterized by abnormal neck pain and movements, and blepharospasm is marked by abnormal, involuntary blinking of spasm of the eyelids. Xeomin is manufactured by Merz Pharmaceuticals.
Xoemin vs. Botox and Dysport
With the new cosmetic approval, Xeomin now joins the ranks of Botox and Dysport. All three approved neurotoxins are very similar, but they do have some important differences. The differences likely mean more to the physician or injector than the consumer. For example, Xeomin is the only one of the three that does not need to be refrigerated before use, which may simplify distribution.
Xoemin is also “naked,” meaning that there are not additives, just botulinum toxin type A. This may mean that there is less risk of developing antibodies against Xeomin than other available neurotoxins. The body develops antibodies in response to a foreign invader and attacks. In theory, antibodies could prevent a neurotoxin from having its desired effects.
The full effects of Xeomin occur within one week, and the results last from three to six months, making it comparable to Botox in terms of both onset and duration of action.
Xoemin is also “naked,” meaning that there are not additives, just botulinum toxin type A. This may mean that there is less risk of developing antibodies against Xeomin than other available neurotoxins. The body develops antibodies in response to a foreign invader and attacks. In theory, antibodies could prevent a neurotoxin from having its desired effects.
Source:
www.yourplasticsurgeryguide.com/injectables-and-fillers/
xeomin-injections.htm
Learn More
For additional information about Xeomin or to schedule an appointment, please call Dr. Alexandra Konowal at 239-948-7555 or visit our website at www.drkonowal.com.